Search

Displaying all 4 results
DrugBest match

Riociguat

go.drugbank.com/drugs/DB08931
ApprovedInvestigational

Riociguat is a soluble guanylate cyclase (sGC) agonist approved in the USA, Europe and several other regions for patients with group I PAH (pulmonary arterial hypertension) in WHO FC II or III; and for the treatment of patients with inoperable CTEPH (chronic thromboembolic pulmonary hypertension), or persistent/recu...

  1. Indication

    Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

    go.drugbank.com/conditions/DBCOND0067384
    Drugs: Riociguat
  2. Indication

    Pulmonary Arterial Hypertension (PAH)

    go.drugbank.com/conditions/DBCOND0039281
    Drugs: Epoprostenol · Macitentan · Riociguat · Sildenafil · Sotatercept · Tadalafil +1 more
  3. Drug

    Vericiguat

    go.drugbank.com/drugs/DB15456
    ApprovedInvestigational

    [L31178] Although not the first sGC stimulator to be granted FDA approval ([riociguat] was approved in 2013 for use in pulmonary hypertension),[L3955] vericiguat is unique amongst its peers in that modifications